TransCelerate accreditation

TransCelerate Accreditation

ICH GCP training (Good Clinical Practice E6 (R2)) performed by BioResearch, which is dedicated for our employees and external entities, was accredited by TransCelerate Biopharma Inc. and so we joined „GCP Mutual Recognition Program"

TransCelerate organisation aim is to unify GCP trainings for Research Teams and confirms that registered trainings fulfill basic program requirements.

GCP certificates which are issued after finishing the training are accepted by Sponsors and representatives of pharmaceuticals companies all over teh world.

BioResearch training was placed on the list of trainings of Transcelerate Biopharma Inc, which is presented at following link: http://www.transceleratebiopharmainc.com/gcp-training-attestation/training-providers/

What makes the training in BioResearch unique and valuable?

Practical approach supported by many years of experience of the Speakers, who as researchers carried out dozens of projects.

Aim

Preparation of researchers and research centers to perform delegated duties in accordance with GCP, local and international law.

To whom

To experienced and beginning researchers, research team: coordinators, pharmacists, lab technicians, nurses and other involved in the project.

Go back

News

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

Read more …

GcLP quality certificate for laboratory procedures

The BRG Clinical Site received the GcLP quality certificate for laboratory procedures and is in the process of obtaining GMP certification for pharmaceutical procedures.

Read more …

Study for healthy people with a drug against Covid-19

In BRG we are currently performing a study for healthy people with a drug against Covid-19 .
In the project we are comparing experimental injectable drug called...

Read more …

Phase I study finished

Our site has just succesfully finished clinical stage of phase I (two parts) study with JAK kinase inhibitors.

Read more …

Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

In BRG we are just starting Study for Healthy People with an Immune Drug - Part B. The aim of the following clinical trial...

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲